» Articles » PMID: 39719504

A 25-year Clonal Resurrection in Adult T-cell Leukemia-lymphoma Relapse

Overview
Journal Int J Hematol
Specialty Hematology
Date 2024 Dec 24
PMID 39719504
Authors
Affiliations
Soon will be listed here.
Abstract

Here, we report a rare case of relapsed adult T-cell leukemia-lymphoma (ATL) with evidence of clonal relapse 26 years after initial diagnosis. The patient had been diagnosed with an aggressive form of lymphoma-type ATL 26 years prior and did not receive further ATL treatment for approximately 26 years after achieving complete remission. We used nested PCR to identify the amplification of ATL clone-specific accumulation sites in DNA from hematoxylin and eosin-stained specimens from the patient. Furthermore, the sequence of amplicons obtained from peripheral blood mononuclear cells and lymphoma cells from the previously diagnosed ATL were identical, indicating that a human T-cell leukemia virus-type 1 (HTLV-1)-infected clone identical to the one that recently caused ATL was present in the original lymphoma tissue. Although we were unable to identify this clone as the cause of the previous ATL, the peripheral leukemia cells revealed an ATL clone that was present in the tumor cells of a lymph node diagnosed 26 years earlier. To our knowledge, this is the first report demonstrating survival of HTLV-1-infected clones for a quarter of a century in a patient with recurrent ATL.

References
1.
Shimoyama M . Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991; 79(3):428-37. DOI: 10.1111/j.1365-2141.1991.tb08051.x. View

2.
Ishitsuka K, Tamura K . Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma. Lancet Oncol. 2014; 15(11):e517-26. DOI: 10.1016/S1470-2045(14)70202-5. View

3.
Utsunomiya A . Progress in Allogeneic Hematopoietic Cell Transplantation in Adult T-Cell Leukemia-Lymphoma. Front Microbiol. 2019; 10:2235. PMC: 6797831. DOI: 10.3389/fmicb.2019.02235. View

4.
Ito A, Nakano N, Tanaka T, Fuji S, Makiyama J, Inoue Y . Improved survival of patients with aggressive ATL by increased use of allo-HCT: a prospective observational study. Blood Adv. 2021; 5(20):4156-4166. PMC: 8945611. DOI: 10.1182/bloodadvances.2021004932. View

5.
Firouzi S, Farmanbar A, Nakai K, Iwanaga M, Uchimaru K, Utsunomiya A . Clonality of HTLV-1-infected T cells as a risk indicator for development and progression of adult T-cell leukemia. Blood Adv. 2018; 1(15):1195-1205. PMC: 5728319. DOI: 10.1182/bloodadvances.2017005900. View